<DOC>
	<DOCNO>NCT00611520</DOCNO>
	<brief_summary>Under daily routine condition without intervention sponsor regard selection subject , diagnostic procedure , therapeutic decision ( medicinal non- medicinal therapy , dose , duration , etc . ) , routine assessment , participate physician ( i.e . pneumologists internist ) ask document relevant data related budesonide/formoterole therapy patient COPD .</brief_summary>
	<brief_title>Symbicort Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>Patients COPD treat budesonide/formoterol limitation ; possible risk ; warning ; contraindication mention SPC .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>treatment COPD</keyword>
	<keyword>related budesonide/formoterole therapy patient COPD .</keyword>
</DOC>